Andiroba (Carapa guianensis)
What Is Andiroba?
Andiroba is the common name for Carapa guianensis, a plant of the Meliaceae family, native to the Amazon and West Africa. The material in circulation is seed oil — the fruiting body of the plant. Most people search for it simply as Andiroba; suppliers, pharmacopoeias and interaction databases list it as Carapa guianensis, and matching the two is the first step in identifying what is actually in a product. Its character is described as bitter woody-nutty, faintly medicinal, which is often how the raw material is checked for quality.
Andiroba entered the reference literature through use rather than through chemistry. Older sources are concerned with where it grows, when it is gathered and how it is prepared, questions that still shape the material on sale today. Beyond its practical use it carries cultural associations — amazonian protective oil against biting spirits and insects alike.
Today most searches for Andiroba come from people reading about wound healing, infection and joint health, or checking how it sits alongside a medication they already take. The use most often documented in the literature is traditional topical anti-inflammatory for bruises, sprains and arthritis, followed by limonoids show documented insect-repellent activity.
How Does Andiroba Work?
Andiroba works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in seed oil rather than by one marker molecule.
The older understanding of Andiroba is procedural rather than molecular — which part to take, in what season, and in what medium — and modern constituent work has largely been an attempt to explain why those procedures were chosen.
Published research is limited, leaning on small trials, laboratory work and animal models, and this profile cites 1 source. Reported findings centre on oil is dominated by oleic and palmitic acid with andirobin, gedunin and 7-deacetoxy-7-oxogedunin limonoids driving anti-inflammatory and repellent activity. Where research exists, it examines traditional topical anti-inflammatory for bruises, sprains and arthritis, limonoids show documented insect-repellent activity and used in Amazonian wound and skin-infection care. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into fixed oil — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
What makes Andiroba distinct is the combination rather than any one molecule: the same compound classes appear in other botanicals, but their ratio here — and the seed oil they are drawn from — is what the traditional and research literature both describe.
Because these constituents are processed by the same pathways that handle many medicines, Andiroba is documented as interacting with topical nsaids. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Andiroba can differ substantially; this is why reference entries specify seed oil and, where they exist, standardisation markers.